A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults

Clinical Nutrition

Volumn 37, Issue 3, 2018, Pages 797-807

  Alfa, Michelle J ^a,b   Strang, David ^c   Tappia, Paramjit S ^a   Graham, Morag ^b,d   Van Domselaar, Gary ^b,d   Forbes, Jessica D ^b,d   Laminman, Vanessa ^d   Olson, Nancy ^a   DeGagne, Pat ^a   Bray, David ^a   Murray, Brenda Lee ^a   Dufault, Brenden ^b   Lix, Lisa M ^b  

^a St Boniface Research Centre   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Deer Lodge   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Bifidobacteria; Butyrate; Canadian adults; Elderly gut microbiome; Prebiotic; Resistant starch

Indexed keywords

BUTYRIC ACID; MSPREBIOTIC; PLACEBO; PREBIOTIC AGENT; RESISTANT STARCH; RNA 16S; SHORT CHAIN FATTY ACID; STARCH; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BUTYRIC ACID DERIVATIVE; VOLATILE FATTY ACID;

ADULT; AGED; ARTICLE; BIFIDOBACTERIUM; CANADIAN; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIGESTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSBIOSIS; ESCHERICHIA COLI; FECES ANALYSIS; GAS CHROMATOGRAPHY; HUMAN; INTESTINE FLORA; MIDDLE AGED; PROSPECTIVE STUDY; PROTEOBACTERIA; RANDOMIZED CONTROLLED TRIAL; RNA SEQUENCE; SHIGELLA; TREATMENT DURATION; AGING; BACTERIUM; BLOOD; CANADA; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; DIET; DRUG EFFECT; FECES; INFLAMMATION; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ADULT; AGED; AGING; BACTERIA; BIOMARKERS; BUTYRATES; CANADA; DIET; DIGESTION; DOUBLE-BLIND METHOD; DYSBIOSIS; FATTY ACIDS, VOLATILE; FECES; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; MIDDLE AGED; PLACEBOS; PREBIOTICS; PROSPECTIVE STUDIES; STARCH;

EID: 85017365187     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2017.03.025     Document Type: Article

References (43)

1. Elaine, Holmes, Kinross, J., Gibson, G.R., Burcelin, R., Jia, W., Pettersson, S., et al. Therapeutic modulation of microbiota-host metabolic interactions. Sci Transl Med, 4, 2012, 10.1126/scitranslmed.3004244 137rv6.
2. Topping, D.L., Clifton, P.M., Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81 (2001), 1031–1064.
3. Ze, X., Duncan, S.H., Louis, P., Flint, H.J., Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 6 (2012), 1535–1543.
4. Belenguer, A., Duncan, S.H., Calder, A.G., Holtrop, G., Louis, P., Lobley, G.E., et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Environ Microbiol 72 (2006), 3593–3599, 10.1128/AEM.72.5.3593-3599.2006.
5. Flint, H.J., Scott, K.P., Duncan, S.H., Louis, P., Forano, E., Microbial degradation of complex carbohydrates in the gut. Gut Microbes 34 (2012), 289–306.
6. Cecchini, D.A., Laville, E., Laguerre, S., Robe, P., Leclerc, M., Dore, J., et al. Functional metagenomics reveals novel pathways of prebiotic breakdown in human gut bacteria. PLoS One, 8, 2013, e72766, 10.1371/journal.pone.0072766.
7. Pokusaeva, K., Fitzgerald, G.F., van Sinderen, D., Carbohydrate metabolism in Bifidobacteria. Genes Nutr 6 (2011), 285–306, 10.1007/s12263-010-0206-6.
8. Brown, K., DeCoffe, D., Molcan, E., Gibson, D.L., Diest-induced dysbiosis of the microbiota and the effects on immunity and disease. Nutrients 4 (2012), 1095–1119, 10.3390/nu4081095.
9. Malaguarnera, A., Leggio, F., Vacante, M., Motta, M., Giordano, M., Biondi, A., et al. Probiotics in the gastrointestinal diseases of the elderly. J Nutr Health Aging 16 (2012), 402–410.
10. Toward, R.E., Montandon, S.L., Walton, G.E., Gibson, G.R., Effect of prebiotics on the human gut microbiota of elderly persons. Gut Microbes 3 (2012), 57–60, 10.4161/gmic.19411.
11. Hardy, H., Harris, J., Lyon, E., Beal, J., Foey, A.D., Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5 (2013), 1869–1912, 10.3390/nu5061869.
12. Biagi, E., Candela, M., Fairweather-Tait, S., Franceschi, C., Brigidi, P., Aging of the human metaorganism: the microbial counterpart. AGE 34 (2012), 247–267, 10.1007/s11357-011-9217-5.
13. Antharam, V.C., Li, E., Ishmael, A., Sharma, A., Mai, V., Rand, K.H., et al. Intestinal dysbiosis and depletion of butyrongenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol, 2013, 10.1128/JCM.00845–13.
14. Claesson, M.J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. PNAS 108 (2011), 4586–4591, 10.1073/pnas.1000097107.
15. Claesson, M.J., Jeffery, I.B., Conde, S., Power, S.E., O'Connor, E.M., Cusack, S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (2012), 178–185, 10.1038/nature11319.
16. Priebe, M.G., Vonk, R.J., Sun, X., He, T., Harmsen, M.J.M., Welling, G.W., The physiology of colonic metabolism. Possibilities for interventions with pre- and probiotics. Eur J Nutr, 41(Suppl 1), 2002, 10.1007/s00394-002-1101-8.
17. O'Callaghan, A., van Sinderen, D., Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol, 2016, 10.3389/fmicb.2016.00925.
18. Patel, R., DuPont, H.L., New approaches for bacteriotherapy: prebiotics, new-generation probiotics and synbiotics. CID 60:S2 (2015), S108–S121.
19. Kleesen, B., Dykura, B., Aunft, H.-J., Blaut, M., Effects of inulin and lactose on fecal microflora, microbial activity and bowel habit in elderly constipated persons. Am J Clin Nutr 65 (1997), 1397–1402.
20. Delzenne, N.M., Neyrinck, A.M., Cani, P.D., Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Factories, 10(Suppl 1), 2011, S10, 10.1186/1475-2859-10-S1-S10.
21. Kolanowski, A., Mulhall, P., Yevchack, A., Hill, N., Fick, D., The triple challenge of recruiting older adults with dementia and high medical acuity in skilled nursing facilities. J Nurs Scholarsh 45 (2013), 397–404.
22. Health Canada Natural Health Product website: (http://webprod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq.do?id=6482&lang=engSolanumTuberosumExtract).
23. Stewart, M.L., Nikhanj, S.D., Timm, D.A., Thomas, W., Slavin, J.L., Evaluation of the effect of four fibers on laxation, gastrointestinal tolerance and serum markers in health humans. Ann Nutr Metab 56 (2010), 91–98, 10.1159/000275962.
24. Illumina 16S Sequencing Laboratory Protocol: http://support.illumina.com/content/dam/illumine-support/documents/documentation/chemistry_documentation/16s/16smetagenomic-library-prep-guide-15044223-b.pdf.
25. Schloss, P.D., Westcott, S.L., Ryabin, T., Hall, J.R., Hartmann, M., Hollister, E.B., et al. Introducing mothur: open- source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75 (2009), 7537–7541.
26. Kozich, J.J., Westcott, S.L., Baxter, N.T., Highlander, S.K., Schloss, P.D., Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol 79:17 (2013), 5112–5120.
27. Pruesse, E., Quast, C., Knittel, K., Fuchs, B.M., Ludwig, W., Peplies, J., et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res 35 (2007), 7188–7196.
28. Wang, Q., Garrity, G.M., Tiedje, J.M., Cole, J.R., Naïve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73 (2007), 5261–5267.
29. Allard, G., Ryan, F.J., Jeffery, I.B., Claesson, M.J., SPINGO: a rapid species-classifier for microbial amplicon sequences. BMC Bioinforma, 16, 2015, 324, 10.1186/s12859-015-0747-1.
30. McMurdie, P.J., Holmes, S., Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One, 8, 2013, e61217.
31. Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2. Genome Biol, 15, 2014, 550, 10.1186/s13059-014-0550-8.
32. Arumugam, M., Raes, J., Pelletier, E., L-Paslier, D., Yamada, T., Mende, D.R., et al. Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180, 10.1038/nature09944.
33. Zhernakova, A., Kurilshikov, A., Bonder, M.J., Tigchelaar, E.T., Schirmer, M., Vatanen, T., Population-based metagenomics analysis reveals markers for gut microiome composition and diversity. Science 352 (2016), 565–569, 10.1126/science.aad3369.
34. Mariat, D., Firmesse, O., Levenez, F., Guimaracs, V.D., Sokol, H., Dore, J., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol, 9, 2009, 123.
35. Nofrarias, M., Martinez-Puig, D., Pujols, J., Majo, N., Perez, J.F., Long-term intake of resistant starch improves mucosal integrity and reduces gut apoptosis and blood immune cells. Nutrition 23 (2007), 861–870.
36. Donohoe, D.R., Garge, N., Zhang, X., Sun, W., O'Connell, T.M., Bunger, M.K., et al. The Microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 13 (2011), 517–526, 10.1016/j.cmet.2011.02.018.
37. Patel, S., Goyal, A., The current trends and future perspectives of prebiotics research: a review. 3 Biotech 2 (2012), 115–125, 10.1007/s13205-012-0044-x.
38. Riviere, A., Selak, M., Lantin, D., Leroy, F., De Vuyst, L., Bifidobacteria and butyrate-producing colon bacteria: importance of strategies for their stimulation in the human gut. Front Microbiol, 7, 2016, 979, 10.3389/fmicb.2016.00979.
39. Rios-Covian, D., Ruas-Madiedo, P., Margolles, A., Gueimonde, M., de los Reyes-Gavilan, C.G., Salazare, N., Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol, 7, 2016, 185, 10.2289/fmicb.2016.00185.
40. Verbeke, K.A., Boobis, Ar, Chiodini, A., Edwards, C.A., Franck, A., Kleerebeem, M., et al. Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr Res Rev 28 (2015), 42–66, 10.1017/S095442241/415000037.
41. Martinez, I., Kim, J., Duffy, P.R., Schlegel, V.L., Walter, J., Resistant starches types 2 and 4 Have differential effects on the composition of the fecal microbiota in human subjects. PLOS One, 5(11), 2010, e15046, 10.1371/journal.pone.0015046.
42. McOrist, A.L., Miller, R.B., Bird, A.R., Keogh, J.B., Noakes, M., Topping, D.L., et al. Fecal butyrate levels very widely among individuals but are usually increased by a diet high in resistant starch. J Nutr 141 (2011), 883–889.
43. Wang, X., Conway, P.L., Brown, I.L., Evans, A.J., In Vitro utilization of amylopectin and high-amylose maize (amylomaize) starch granules by human colonic bacteria. Appl Environ Microbiol 65 (1999), 4848–4854.